All Products

Featured Products

Newest Products

Research Areas

VEGFR Products

or product name starting with: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  
405580
ZM306416
featured
ZM306416 is a selective VEGFR1 inhibitor. ZM306416 antagonizes the activity of KDR and Flt VEGF rec…
406473
SU5402
featured
SU5402 is a potent and selective vascular endothelial growth factor receptor (VEGFR) and fibroblast …
401970
SKLB610
featured
SKLB610 is a VEGFR inhibitor that potently suppresses human tumor angiogenesis. SKLB610 inhibited an…
401915
SIM010603
SIM010603 is a structurally novel, oral, multi-targeted receptor tyrosine kinase inhibitor. SIM01060…
406172
NVP-BHG712
featured
NVP-BHG712, also known as BHG-712, is a EphB4 kinase inhibitor and BCR-ABL inhibitor. NVP-BHG712 inh…
406351
Ki8751
featured
Ki8751 is a potent, selective inhibitor of VEGFR-2 tyrosine kinase (IC50 = 0.9 nM). Displays some in…
406108
FIIN-1
featured
FIIN-1 is Potent, irreversible FGFR inhibitor, acts at the ATP binding site. Also irreversibly inhib…
406287
AAL-993
featured
AAL-993 is a highly potent inhibitor of VEGFR-1 (IC50 =130nM), VEGFR-2 (IC50=23nM) and VEGFR-3 (IC50…
206025
ZK-304709
ZK-304709 is a potent multi-target tumor growth inhibitor with IC50 = nanomolar inhibitory activity …
205665
XL999
XL999, a Spectrum Selective Kinase Inhibitor(TM) (SSKIs), is a potent inhibitor of key RTKs implicat…
205930
XL-844
XL-844 is a synthetic small-molecule inhibitor of checkpoint kinases 1 and 2 (Chk1 and Chk2) with po…
203186
Tesevatinib
featured
Tesevatinib, also known as XL647, EXEL-7647 and KD-019, is a n orally bioavailable small-molecule re…
203110
Vatalanib HCl
featured
Vatalanib, also known as PTK787, is an orally bioavailable anilinophthalazine with potential antine…
206321
Orantinib
featured
Orantinib, also known as TSU-68；SU6668, is an orally bioavailable receptor tyrosine kinase inhibitor…
200955
Tivozanib
featured
Tivozanib, also known as KRN951, is an orally bioavailable inhibitor of vascular endothelial growth…
202722
TAK-593
TAK-593 is a n oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of bo…
206205
Sulfatinib
new
featured
Sulfatinib, also known as surufatinib, is an orally bioavailable, small molecule inhibitor of vascul…
205916
PF-00337210
PF-00337210 is an orally available ATP-competitive inhibitor of the vascular endothelial growth fact…
202100
OSI-930
new
featured
OSI-930 is a selective thiophene-derived tyrosine kinase inhibitor with potential antineoplastic act…
201934
Motesanib
featured
Motesanib, also known as AMG-706, is the orally bioavailable multiple-receptor tyrosine kinase inhib…
201841
MGCD-265-analog
featured
MGCD265-analog, CAS#875337-44-3, is structurally related to MGCD-265 (Glesatinib). MGCD-265-analog i…
201080
Lenvatinib mesylate
featured
Lenvatinib, also known as E7080, is a synthetic, orally available inhibitor of vascular endothelial …
201611
JI-101
featured
JI-101 is an orally active inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2), plat…
205845
Henatinib
Henatinib maleate is t he maleate salt form of henatinib, an orally bioavalable, multitargeted tyros…
205798
GFB-204
GFB-204 is a calixarene derivative that is a potent and selective inhibitor of VEGFR and PDGFR tyros…
201372
Foretinib
featured
Foretinib, also known as XL880 and GSK1363089, is an orally bioavailable small molecule with potenti…
205837
Lucitanib
featured
Lucitanib , also known as E-3810 and AL3810, is a novel dual inhibitor targeting human vascular endo…
200851
Rebastinib
featured
Rebastinib, also known as DCC-2036, is an orally bioavailable small-molecule inhibitor of multiple t…
200810
CP-547632
featured
CP-547632, also known as PAN-90806, is as a potent inhibitor of the VEGFR-2 and basic fibroblast gr…
200770
RAF-265 (CHIR-265)
featured
RAF-265, also known as CHIR-265, is an orally bioavailable small molecule with potential antineoplas…
200712
CEP-11981
CEP-11981, also known as ESK981, is an orally bioavailable inhibitor of vascular endothelial growth …
200690
Cediranib free base
featured
Cediranib, also known as AZD-2171, is a potent and selective VEGF inhibitor with antineoplastic acti…
200533
BMS-690514
BMS-690514 is a potent inhibitor of human epidermal growth factor receptor (HER) 1 (EGFR), 2, and 4,…
200294
Pexmetinib
featured
Pexmetinib, also known as ARRY-614, is an orally bioavailable small-molecule inhibitor of p38 and Ti…
206058
Anlotinib HCl
new
featured
Anlotinib, also known as AL3818 and Catequentinib, is a receptor tyrosine kinase (RTK) inhibitor wit…
200100
AEE-788
featured
AEE-788 is an orally bioavailable multiple-receptor tyrosine kinase inhibitor. AEE788 inhibits phosp…
401120
AZD-2932
featured
AZD-2932 is a high affinity inhibitor of VEFGR-2 and PDGFR. AZD-2932 has a balanced ~ 1:1 ratio of a…
401158
BX795
featured
BX795 is a potent PDK1 inhibitor. BX795 also suppresses MARK1, MARK2, MARK4, NUAK1,
200760
Dovitinib lactate
featured
Dovitinib, also known as TKI-258 or CHIR-258, is an orally bioavailable FGFR3 inhibitor, which stron…
406121
WHI-P154
featured
WHI-P154 is a JAK3 inhibitor with IC50 = 1.8 microM. WHI-P154 displays no activity at JAK1 or JAK2. …
558308
Vandetanib
featured
Vandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyros…
202710
SU14813
featured
SU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial gro…
406387
SSR128129E
featured
SSR128129E (SSR) is an potent FGFR inhibitor, which inhibits fibroblast growth factor receptor (FGFR…
205994
Semaxanib
featured
Semaxanib, also known as SU5416, is a quinolone derivative with potential antineoplastic activity. S…
202391
R1530
featured
R1530 is a pyrazolobenzodiazepine small molecule with potential antiangiogenesis and antineoplastic …
202161
Pazopanib
featured
Pazopanib is an approved drug, is a small molecule inhibitor of multiple protein tyrosine kinases wi…
406288
KRN633
featured
KRN633 is a potent and selective VEGFR inhibitor. which inhibits tyrosine phosphorylation of VEGFR-2…
201072
Golvatinib
featured
Golvatinib, also known as E7050, is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyt…
200595
Cabozantinib (free base)
featured
Cabozantinib, also known as XL-184 and BMS-907351, is the s-malate salt form of cabozantinib, an or…
200400
Axitinib
featured
Axitinib, also known as AG013736, is an orally bioavailable tyrosine kinase inhibitor. Axitinib inhi…